First-in-man trial of beta3-adrenoceptor agonist treatment in chronic heart failure - impact on diastolic function. Zohori Bahrami HS, Hasselbalch RB, Soholm H, Thomsen JH, et al. J Cardiovasc Pharmacol 2024 Mar 5. doi: 10.1097/FJC.0000000000001545.

Read + Share

Amedeo Smart

Independent Medical Education

Zohori Bahrami HS, Hasselbalch RB, Soholm H, Thomsen JH, et al. First-in-man trial of beta3-adrenoceptor agonist treatment in chronic heart failure - impact on diastolic function. J Cardiovasc Pharmacol 2024 Mar 5. doi: 10.1097/FJC.0000000000001545.
PMID: 38452283